TheraSonic, a CEA spin-off created end of 2023, closes a fundraising led by the venture studio M2care for the development of a breakthrough technology designed to improve drug delivery into the brain
TheraSonic, a startup founded at the end of 2023 and emerging from CEA, announces a fundraising of €1 million to finance the development of its robotic medical device designed to improve drug delivery in the brain through the use of focused ultrasound.
La Dr Ines Vaz Luis, oncologue médicale et chercheuse, est une spécialiste internationale de la qualité de vie après- cancer (survivorship) et de son évaluation